Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants

Clinical trial NCT05274100 · COMPLETED

Trial details

NCT number: NCT05274100
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-09-01
Primary completion: 2021-07-06
Enrollment: 394

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.